New York Times: The Pfizer-BioNTech vaccine is incredibly effective against severe disease caused by two variants, studies say.
The Washington Post: Pfizer-BioNTech vaccine offers strong protection against key variants of concern, real-world data from Qatar shows
Dr. Gheyath K. Nasrallah’s lab has been awarded the NPRP13S-0128-200185 ($596,000): Low-Cost Magnetic Lateral Flow Assay Platform for Rapid Food Safety Testing and Point-of-Care Viral Infection Diagnostics in Qatar.
